Nursing Diagnosis of Activity Intolerance: Clinical Validation in Patients With Refractory Angina.
Rodrigues CG, Moraes MA, Sauer JM, Kalil RAK, de Souza EN.
Int J Nurs Terminol Classif. 2011;22(3):117-22.

Hidden renal dysfunction causes increased in-hospital mortality risk after coronary artery bypass graft surgery.
Volkmann MA, Behr PEB, Burmeister JE, Consoni PR, Kalil RAK, Prates PR, et al.
Rev Bras Cir Cardiovasc. 2011;26(3):319-25.

Endothelial Function After VEGF 165 Gene Therapy in End-Stage Ischemic Cardiac Disease: Preliminary Results.
Dipp T, Kalil RAK, Rodrigues CG, Salles FB, Giusti IIS, Santanna RT, et al.
World Congress of Cardiology Scientific Sessions; Jul; Beijing, China: Circulation; 2010. p. E150.

VEGF gene therapy for angiogenesis in refractory angina: Phase I/II clinical trial.
Kalil RAK, de Salles FB, Giusti, II, Rodrigues CG, Han SW, Sant’Anna RT, et al.
Rev Bras Cir Cardiovasc. 2010;25(3):311-21.

Terapia gênica com VEGF para angiogênese na angina refratária: ensaio clínico fase I/II.
Kalil RAK, Salles FBd, Giusti II, Rodrigues CG, Han SW, Sant’anna RT, et al.
Braz J Cardiovasc Surg. 2010;25(3):311-21.

Incidence of Pulmonary Complications in Myocardial Revascularization.
Ortiz LDN, Schaan CW, Leguisamo CP, Tremarin K, Mattos W, Kalil RAK, et al.
Arq Bras Cardiol. 2010;95(4):441-7.

Incidência de complicações pulmonares na cirurgia de revascularização do miocárdio.
Ortiz LDN, Schaan CW, Leguisamo CP, Tremarin K, Mattos WLLD, Kalil RAK, et al.
Arq Bras Cardiol. 2010;95(4):441-7.

Comparison of surgical cut and sew versus radiofrequency pulmonary veins isolation for chronic permanent atrial fibrillation: a randomized study.
Pires LM, Leiria TLL, de Lima GG, Kruse ML, Nesralla IA, Kalil RAK.
Pacing Clin Electrophysiol. 2010;33(10):1249-57.

Morbimortality in Octogenarian Patients Submitted to Myocardial Revascularization Surgery.
Pivatto F, Kalil RAK, Costa AR, Pereira EMC, Santos EZ, Valle FH, et al.
Arq Bras Cardiol. 2010;95(1):41-6.

Hospital Risk Factors for Patients Submitted to Heart Valve Replacement with St Jude-Biocor Bovine Pericardium Bioprosthesis.
Sant’Anna JRM, De Bacco F, Paiva JV, Sant’Anna R, Fornari LH, Santos MF, et al.
Circulation. 2010;122(2):e145.

Risk Factors for Cardiac Valve Replacement with St Jude Mechanical Prosthesis.
Sant’Anna JRM, De Bacco M, Sant’Anna R, Gil AGM, Sartori AP, Santos MF, et al.
Circulation. 2010;122(2):e145.

Global Contractility Increment in Nonischemic Dilated Cardiomyopathy After Free Wall Only Intramyocardial Injection of Autologous Bone Marrow Mononuclear Cells: An Insight Over Stem Cells Clinical Mechanism of Action.
Sant’Anna R, Kalil RAK, Neto AP, Pivatto F, Sant’Anna JRM, Marques M, et al.
Circulation. 2010;122(2):e318.

Global Contractility Increment in Nonischemic Dilated Cardiomyopathy After Free Wall Only Intramyocardial Injection of Autologous Bone Marrow Mononuclear Cells: An Insight Over Stem Cells Clinical Mechanism of Action.
Sant’anna RT, Kalil RA, Pretto Neto AS, Pivatto Junior F, Fracasso J, Sant’anna JR, et al.
Cell Transplant. 2010;19(8):959-64.

Morbidity and mortality in patients aged over 75 years undergoing surgery for aortic valve replacement.
Valle FH, Costa AR, Pereira EMC, Santos EZ, Pivatto F, Bender LP, et al.
Arq Bras Cardiol. 2010;94(6):720-5.

Morbimortalidade em pacientes acima de 75 anos submetidos à cirurgia por estenose valvar aórtica.
Valle FH, Costa AR, Pereira EMC, Santos EZ, Pivatto Júnior F, Bender LP, et al.
Arq Bras Cardiol. 2010;94:720-5.

Randomized study of surgical isolation of the pulmonary veins for correction of permanent atrial fibrillation associated with mitral valve disease.
Albrecht A, Kalil RAK, Schuch L, Abrahao R, Sant’Anna JRM, de Lima G, et al.
J Thorac Cardiovasc Sur. 2009;138(2):454-9.

Risk factors for hospital mortality in valve replacement with mechanical prosthesis.
Bacco MWd, Sartori AP, Sant’Anna JRM, Santos MF, Prates PR, Kalil RAK, et al.
Rev Bras Cir Cardiovasc. 2009;24(3):334-40.

Effects of therapeutic angiogenesis with plasmid VEGF(165) on ventricular function in a canine model of chronic myocardial infarction.
Furlani AP, Kalil RAK, Castro I, Canedo-Delgado A, Barra M, Prates PR, et al.
Rev Bras Cir Cardiovasc. 2009;24(2):143-9.

Aplicabilidade do escore de risco de Ambler para pacientes com substituição valvar por bioprótese de pericárdio bovino.
Bacco Gd, Bacco MWd, Sant’anna JRM, Santos MF, Sant’anna RT, Prates PR, et al.
Rev Bras Cir Cardiovasc. 2008;23(3):336-43.

Applicability of Ambler’s risk score to patients who have undergone valve replacement with bovine pericardial bioprosthesis.
Bacco Gd, Bacco MW, Sant’Anna JRM, Santos MF, Sant’Anna RT, Prates PR, et al.
Rev Bras Cir Cardiovasc. 2008;23(3):336-43.

< anterior [ 4 / 10 ] próxima >
<< primeira | última >>